Claritas Pharmaceuticals, Inc.
CLAZF
Rank in Stocks
#34712
Operating as a clinical-stage specialty pharmaceutical entity, Claritas... Operating as a clinical-stage specialty pharmaceutical entity, Claritas Pharmaceuticals, Inc. is dedicated to the creation and market introduction of medical therapies addressing significant patient needs that are currently unfulfilled. Established in 2014, the company was previously known as Kalytera Therapeutics, Inc. before rebranding to Claritas Pharmaceuticals, Inc. in April 2021. Its corporate headquarters are located in San Rafael, California.
Share Price
$0.0001
Last synced: 2026-11-10
Market Cap
$3.54K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Claritas Pharmaceuticals, Inc. (CLAZF)
Category
Healthcare
EPS for Claritas Pharmaceuticals, Inc. (CLAZF)
EPS as of September 2021 TTM: $-0.16
According to Claritas Pharmaceuticals, Inc.'s latest financial reports, its current EPS (TTM) is $-0.16. At the end of 2020 the company had an EPS of $0.16, an increase over its 2019 EPS of $-0.95.
EPS history for Claritas Pharmaceuticals, Inc. from 2005 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.16 | -200.00% |
| 2020 | $0.16 | -116.84% |
| 2019 | $-0.95 | -248.44% |
| 2018 | $0.64 | -112.31% |
| 2017 | $-5.20 | -33.84% |
| 2016 | $-7.86 | 309.38% |
| 2015 | $-1.92 | 308.51% |
| 2014 | $-0.47 | -99.74% |
| 2013 | $-183.89 | -19.01% |
| 2012 | $-227.04 | 8.41% |
| 2011 | $-209.42 | 19.07% |
| 2010 | $-175.88 | -28.50% |
| 2009 | $-245.99 | -77.86% |
| 2008 | $-1.11K | 198.53% |
| 2007 | $-372.20 | 12.68% |
| 2006 | $-330.32 | 163.52% |
| 2005 | $-125.35 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $-0.89 | 456.25% |
US
|
|
| $15.66 | -9,887.50% |
US
|
|
| $-7.07 | 4,318.75% |
US
|
|
| $-5.29 | 3,206.25% |
AU
|
|
| $12.73 | -8,057.63% |
BE
|
Questions about Claritas Pharmaceuticals, Inc.'s earnings per share (EPS)
What is Claritas Pharmaceuticals, Inc.'s earnings per share (EPS)?
Claritas Pharmaceuticals, Inc.'s earnings per share (EPS) over the last twelve months is $-0.16, as of Sep 2021.
What was Claritas Pharmaceuticals, Inc.'s earnings per share (EPS) in 2020?
In 2020, Claritas Pharmaceuticals, Inc.'s earnings per share (EPS) was $0.16, compared with $-0.95 in 2019.
How has Claritas Pharmaceuticals, Inc.'s earnings per share (EPS) changed since 2015?
From 2015 to 2020, Claritas Pharmaceuticals, Inc.'s earnings per share (EPS) was highest in 2018 ($0.64) and lowest in 2016 ($-7.86).
How does Claritas Pharmaceuticals, Inc.'s earnings per share (EPS) compare with similar companies?
Claritas Pharmaceuticals, Inc.'s earnings per share (EPS) ($-0.16) is higher than that of 3 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with $15.66.